Seroatlas · Human Serome Atlas

GPS2

G protein pathway suppressor 2

Also known as: GPS2_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q13227
Gene
GPS2
Ensembl
ENSG00000132522
Chromosome
17
Canonical length
327 aa
Protein class
Cancer-related genes, Predicted intracellular proteins
Subcellular location
Nucleoplasm

OverviewNCBI Gene

This gene encodes a protein involved in G protein-mitogen-activated protein kinase (MAPK) signaling cascades. When overexpressed in mammalian cells, this gene could potently suppress a RAS- and MAPK-mediated signal and interfere with JNK activity, suggesting that the function of this gene may be signal repression. The encoded protein is an integral subunit of the NCOR1-HDAC3 (nuclear receptor corepressor 1-histone deacetylase 3) complex, and it was shown that the complex inhibits JNK activation through this subunit and thus could potentially provide an alternative mechanism for hormone-mediated antagonism of AP1 (activator protein 1) function. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

327 residues, UniProt reviewed canonical sequence.

>Q13227|GPS2
     1  MPALLERPKL SNAMARALHR HIMMERERKR QEEEEVDKMM EQKMKEEQER RKKKEMEERM
    61  SLEETKEQIL KLEEKLLALQ EEKHQLFLQL KKVLHEEEKR RRKEQSDLTT LTSAAYQQSL
   121  TVHTGTHLLS MQGSPGGHNR PGTLMAADRA KQMFGPQVLT TRHYVGSAAA FAGTPEHGQF
   181  QGSPGGAYGT AQPPPHYGPT QPAYSPSQQL RAPSAFPAVQ YLSQPQPQPY AVHGHFQPTQ
   241  TGFLQPGGAL SLQKQMEHAN QQTGFSDSSS LRPMHPQALH PAPGLLASPQ LPVQMQPAGK
   301  SGFAATSQPG PRLPFIQHSQ NPRFYHK

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against GPS2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.66
Highest tissue expression
174 nTPM

Expression across tissuesHPA

Tissue

  • skeletal muscle: 174 nTPM
  • testis: 120 nTPM
  • heart muscle: 77 nTPM
  • blood vessel: 73 nTPM
  • kidney: 66 nTPM
  • adrenal gland: 62 nTPM

Single-cell type

  • oligodendrocytes: 43 nCPM
  • bergmann glia: 42 nCPM
  • brain excitatory neurons: 40 nCPM
  • microglia: 39 nCPM
  • astrocytes: 36 nCPM
  • brain inhibitory neurons: 34 nCPM

Immune cell

  • eosinophil: 83 nTPM
  • memory B-cell: 82 nTPM
  • T-reg: 81 nTPM
  • neutrophil: 79 nTPM
  • basophil: 79 nTPM
  • non-classical monocyte: 68 nTPM

Brain region

  • cerebral cortex: 28 nTPM
  • medulla oblongata: 21 nTPM
  • white matter: 20 nTPM
  • pons: 20 nTPM
  • thalamus: 20 nTPM
  • hypothalamus: 19 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about GPS2.

Disease | ImmuneIEDB

Conditions an epitope on GPS2 was assayed in.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.58
gnomAD pLI
0.05
gnomAD missense Z
1.16
DepMap mean gene effect
-0.09
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

  • G protein pathway suppressor 2
  • G-protein pathway suppressor

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of GPS2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads GPS2 as an antibody target. Whether an autoantibody or antibody against GPS2 could matter depends on whether native GPS2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

GPS2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label GPS2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/GPS2. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...